Rekombinanter ITGAL (Efalizumab Biosimilar) Antikörper

Produktnummer ABIN5668045

Produktdetails anti-ITGAL (Efalizumab Biosimilar) Antikörper

Target: ITGAL (Efalizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser ITGAL (Efalizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Blocking Reagent (BR), Flow Cytometry (FACS)

Spezifität: Binds to human LFA-1.

Produktmerkmale:

OriginalSpeciesName: Human

OriginalFormat: IgG1

Aufreinigung: Purified antibody.

Reinheit: > 98 % as determined by SDS-PAGE

Endotoxin-Niveau: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Klon: Hu1124

Isotyp: IgG kappa

Anwendungsinformationen

Applikationshinweise: Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.

Kommentare:

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu ITGAL (Efalizumab Biosimilar)

Target: ITGAL (Efalizumab Biosimilar)

Abstract: ITGAL (Efalizumab Biosimilar) Produkte

Synonyme: CD11A antikoerper, LFA-1 antikoerper, LFA1A antikoerper, integrin subunit alpha L antikoerper, ITGAL antikoerper

Substanzklasse: Biosimilar

Hintergrund: LFA-1, integrin alpha L

UniProt: P20701